Health assessment using percutaneous optical imaging in patients with esophageal cancer and esophagogastric junction cancer: a prospective observational study

Health assessment using percutaneous optical imaging in patients with esophageal cancer and esophagogastric junction cancer: a prospective observational study - Health assessment using percutaneous optical imaging in patients with esophageal cancer and esophagogastric junction cancer: a prospective observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051870

Enrollment

Registered

2023-08-09

Start date

2023-08-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer and esophagogastric junction cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with esophageal cancer or esophagogastric junction cancer. 2) Patients who are 20 years of age or older at the time of consent. 3) Patients who have been fully informed of the study and who have given written consent of their own will.

Exclusion criteria

Exclusion criteria: Patients who are deemed by the investigator or subinvestigator to be unsuitable for this study.

Design outcomes

Primary

Measure	Time frame
Correlation between the features derived from RGB values obtained by percutaneous optical imaging and QOL scores	—

Secondary

Measure	Time frame
Correlation between the features derived from RGB values obtained by percutaneous optical imaging and the clinical data such as vital signs, weight, blood data, and clinical outcomes	—

Countries

Japan

Contacts

Public ContactMurakami Kentaro

Graduate School of Medicine, Chiba University Department of Frontier Surgery

murakami2621@chiba-u.jp81-43-226-2110

Outcome results